search
Back to results

Training Therapists to Administer Contingency Management-Patient Phase - 3

Primary Purpose

Substance Abuse

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Contingency management
Sponsored by
UConn Health
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Substance Abuse focused on measuring Contingency Management, Substance Abuse Treatment

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria: age 18 years or older meets DSM-IV criteria for cocaine abuse or dependence English speaking (est. >90% of patients) For those in drug-free programs, they must have initiated treatment within the past week. For methadone patients, they must be stabilized on a dose of methadone, defined as being on the same dose for at least 30 days and not currently requesting or being considered for a dose modification. Methadone patients must also have submitted at least 30% cocaine positive urine samples in the past 3 months. Exclusion criteria: acute uncontrolled psychiatric disorder (psychosis, suicidality) as determined by the SCID dementia (<23 on the Mini Mental State Exam; Folstein & Folstein, 1975) in recovery for pathological gambling

Sites / Locations

  • University of Connecticut Health Center

Outcomes

Primary Outcome Measures

Drug use
Retention

Secondary Outcome Measures

Full Information

First Posted
November 3, 2005
Last Updated
November 17, 2011
Sponsor
UConn Health
Collaborators
National Institute on Drug Abuse (NIDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00249418
Brief Title
Training Therapists to Administer Contingency Management-Patient Phase - 3
Official Title
Training Therapists to Administer Contingency Management-Patient Phase
Study Type
Interventional

2. Study Status

Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
January 2004 (undefined)
Primary Completion Date
September 2009 (Actual)
Study Completion Date
September 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
UConn Health
Collaborators
National Institute on Drug Abuse (NIDA)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to train therapists to administer contingency management (CM). This project will train up to 42 community-based treatment providers about the rationale for and the specifics of administering CM. Initial training will occur in 2-day workshops, followed by weekly supervision in delivery of CM with test cases. We expect that the majority of therapists will achieve high levels of competence and adherence in administering CM treatment within 3-5 test cases, as measured by ratings of audiotapes. To examine the efficacy of CM, each therapist who achieves adherence and competence in delivering CM will administer standard treatment alone or standard treatment plus CM to substance-abusing outpatients. In the CM condition, patients will have the opportunity to win prizes for submission of negative samples, and the treatment will be in effect for 12 weeks. In total, up to 200 patients will be randomly assigned to one of the two conditions. A research evaluator will conduct follow-up assessments, scheduled for 3, 6 and 9 months after treatment initiation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance Abuse
Keywords
Contingency Management, Substance Abuse Treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
180 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Contingency management
Intervention Description
Rewards (prizes) for abstinence
Primary Outcome Measure Information:
Title
Drug use
Time Frame
baseline and each follow-up
Title
Retention
Time Frame
each follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: age 18 years or older meets DSM-IV criteria for cocaine abuse or dependence English speaking (est. >90% of patients) For those in drug-free programs, they must have initiated treatment within the past week. For methadone patients, they must be stabilized on a dose of methadone, defined as being on the same dose for at least 30 days and not currently requesting or being considered for a dose modification. Methadone patients must also have submitted at least 30% cocaine positive urine samples in the past 3 months. Exclusion criteria: acute uncontrolled psychiatric disorder (psychosis, suicidality) as determined by the SCID dementia (<23 on the Mini Mental State Exam; Folstein & Folstein, 1975) in recovery for pathological gambling
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nancy Petry, Ph.D.
Organizational Affiliation
UConn Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Connecticut Health Center
City
Farmington
State/Province
Connecticut
ZIP/Postal Code
06030
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Training Therapists to Administer Contingency Management-Patient Phase - 3

We'll reach out to this number within 24 hrs